Overview of the Hatch-Waxman Act and its impact on the drug development process.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to G J Mossinghoff.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Consumer choice among competing private plans should be strengthened, rather than lending support to the mandate for a government single-payer plan. A major theme running through this position paper is that drugs are not only the most cost-effective form of medical treatment, but they represent only a small share of the national health care expenditures. In this article, the author focuses on defending three guiding principles for reform: (1) all Americans should have prescription-drug coverage; (2) competition can and must be relied on to control costs; and (3) the discovery of new cures must be actively encouraged through adequate incentives for the pharmaceutical industry.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.